Regeneron Investor Sues Execs, Alleging Kickback Scheme
Regeneron leadership was hit with a derivative shareholder suit over claims the company's former and current executives and board members reaped over $650 million in sales of stock whose value was...To view the full article, register now.
Already a subscriber? Click here to view full article